Comparison the effect of vaginal versus sublingual misoprostol in termination of pregnancy of 12-24 weeks
Phase 2
- Conditions
- Pregnancy, childbirth and the puerperium.Medical abortion
- Registration Number
- IRCT201106213485N3
- Lead Sponsor
- Vice Chancellor for research, Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 268
Inclusion Criteria
Inclusion criteria : 12-24 weeks single pregnancy confirmed with certain LMP and > 20 weeks sonography
Exclusion criteria : Known sensitivity to prostaglandins (questions such as skin rash, wheels, dyspnea, cough, chest pain, blurred vision); previous caesarian section; Vaginal bleeding; placenta previa; Parity > 3
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparing the effect of vaginal versus sublingual misoprostol in termination of pregnancy. Timepoint: Each 3 hours to 24 hours then if the pregnancy isn’t terminated misoprostol will be continued each 3 hours to 48 hours. Method of measurement: Observation of fetus expulsion.
- Secondary Outcome Measures
Name Time Method